DE2405394A1 - Medikamenten-packung fuer die behandlung des klimakterischen syndroms - Google Patents
Medikamenten-packung fuer die behandlung des klimakterischen syndromsInfo
- Publication number
- DE2405394A1 DE2405394A1 DE19742405394 DE2405394A DE2405394A1 DE 2405394 A1 DE2405394 A1 DE 2405394A1 DE 19742405394 DE19742405394 DE 19742405394 DE 2405394 A DE2405394 A DE 2405394A DE 2405394 A1 DE2405394 A1 DE 2405394A1
- Authority
- DE
- Germany
- Prior art keywords
- estrogen
- pack according
- treatment
- daily doses
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000011580 syndromic disease Diseases 0.000 title claims description 5
- 229940011871 estrogen Drugs 0.000 claims description 41
- 239000000262 estrogen Substances 0.000 claims description 41
- 239000003814 drug Substances 0.000 claims description 20
- 239000000902 placebo Substances 0.000 claims description 15
- 229940068196 placebo Drugs 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 10
- 238000002560 therapeutic procedure Methods 0.000 claims description 9
- 229940035811 conjugated estrogen Drugs 0.000 claims description 7
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 claims description 4
- QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical group [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 claims description 4
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims description 4
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 claims description 3
- 229960003399 estrone Drugs 0.000 claims description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims description 2
- 206010067572 Oestrogenic effect Diseases 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 230000001076 estrogenic effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 229960004766 estradiol valerate Drugs 0.000 claims 1
- 229960001348 estriol Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010027304 Menopausal symptoms Diseases 0.000 description 5
- 208000034158 bleeding Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- 208000033830 Hot Flashes Diseases 0.000 description 2
- 206010060800 Hot flush Diseases 0.000 description 2
- 206010047998 Withdrawal bleed Diseases 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010024434 Lichen sclerosus Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000008480 vulvar lichen sclerosus Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH201573 | 1973-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2405394A1 true DE2405394A1 (de) | 1974-08-15 |
Family
ID=4223903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19742405394 Pending DE2405394A1 (de) | 1973-02-13 | 1974-02-05 | Medikamenten-packung fuer die behandlung des klimakterischen syndroms |
Country Status (13)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3229612A1 (de) * | 1981-08-10 | 1983-02-24 | Syntex (U.S.A.) Inc., 94304 Palo Alto, Calif. | Pharmazeutische packung |
| EP0308551A1 (en) * | 1986-03-18 | 1989-03-29 | Gynex, Inc., | Package for oral contraceptive tablet |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60168830U (ja) * | 1984-04-20 | 1985-11-09 | 梶間 定勇 | 薬剤パツク |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1195534A (en) * | 1966-07-18 | 1970-06-17 | John Rae | Drug Packs |
| NL6615481A (enrdf_load_stackoverflow) * | 1966-11-02 | 1968-05-03 | ||
| AU4168068A (en) * | 1969-07-22 | 1971-01-28 | Unisearch Limited | Improvements in or relating to oral contraceptives |
-
1974
- 1974-01-24 IE IE139/74A patent/IE38781B1/xx unknown
- 1974-01-24 CA CA190,825A patent/CA1019676A/en not_active Expired
- 1974-01-28 IL IL44094A patent/IL44094A/en unknown
- 1974-02-05 DE DE19742405394 patent/DE2405394A1/de active Pending
- 1974-02-11 GB GB613474A patent/GB1459485A/en not_active Expired
- 1974-02-11 AU AU65434/74A patent/AU6543474A/en not_active Expired
- 1974-02-11 FR FR7404495A patent/FR2235674B1/fr not_active Expired
- 1974-02-11 LU LU69365A patent/LU69365A1/xx unknown
- 1974-02-12 BE BE140795A patent/BE810893A/xx unknown
- 1974-02-12 ZA ZA740906A patent/ZA74906B/xx unknown
- 1974-02-13 JP JP49017526A patent/JPS49110817A/ja active Pending
- 1974-02-13 MC MC1091A patent/MC999A1/xx unknown
- 1974-02-13 NL NL7401996A patent/NL7401996A/xx not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3229612A1 (de) * | 1981-08-10 | 1983-02-24 | Syntex (U.S.A.) Inc., 94304 Palo Alto, Calif. | Pharmazeutische packung |
| EP0308551A1 (en) * | 1986-03-18 | 1989-03-29 | Gynex, Inc., | Package for oral contraceptive tablet |
Also Published As
| Publication number | Publication date |
|---|---|
| IL44094A (en) | 1976-09-30 |
| JPS49110817A (enrdf_load_stackoverflow) | 1974-10-22 |
| MC999A1 (fr) | 1974-10-18 |
| GB1459485A (en) | 1976-12-22 |
| IL44094A0 (en) | 1974-05-16 |
| LU69365A1 (enrdf_load_stackoverflow) | 1975-12-09 |
| NL7401996A (enrdf_load_stackoverflow) | 1974-08-15 |
| FR2235674B1 (enrdf_load_stackoverflow) | 1978-01-06 |
| IE38781L (en) | 1974-08-13 |
| FR2235674A1 (enrdf_load_stackoverflow) | 1975-01-31 |
| BE810893A (fr) | 1974-08-12 |
| AU6543474A (en) | 1975-08-14 |
| CA1019676A (en) | 1977-10-25 |
| ZA74906B (en) | 1974-12-24 |
| IE38781B1 (en) | 1978-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69432752T2 (de) | Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält | |
| DE3855606T2 (de) | Verwendung von Melatonin zur Herstellung einer kontrazeptiven Zusammensetzung | |
| DE3486442T2 (de) | Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür | |
| DE69118494T2 (de) | Kontrazeptionsverfahren und Schema | |
| DE4344405C2 (de) | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption | |
| DE68928897T2 (de) | Verfahren und system zur empfängnisverhütung | |
| DE4104385C1 (enrdf_load_stackoverflow) | ||
| DE19739916C2 (de) | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
| DE69804918T2 (de) | Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung | |
| DE19705229C2 (de) | Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen | |
| EP0628312B1 (de) | Kombinationspräparat zur Kontrazeption | |
| DE3888269T2 (de) | Hormon-Zusammensetzung und -Anwendung. | |
| EP0868188B1 (de) | Kit zur kontrazeption bei weiblichen säugern, bestehend aus einer kombination von gestagen und estrogen | |
| DE3213248A1 (de) | Pharmazeutische packung zur behandlung von symptomen der menopause bei frauen | |
| DE3229612A1 (de) | Pharmazeutische packung | |
| DE69729956T2 (de) | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält | |
| EP0148724A1 (de) | Mehrstufenkombinationspräparat und seine Verwendung zur oralen Kontrazeption | |
| WO1998027929A2 (de) | Therapeutische gestagene zur behandlung von premenstrual dysphoric disorder | |
| DE1617686A1 (de) | Verfahren zur Anregung von Ovulationszyklen und pharmazeutische Verpackungseinheiten | |
| DE19531936A1 (de) | Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend | |
| DE2405394A1 (de) | Medikamenten-packung fuer die behandlung des klimakterischen syndroms | |
| DD238921A5 (de) | Verfahren zur herstellung einer kontrazeptiven synergistischen zusammensetzung | |
| DE69827017T2 (de) | Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung | |
| DE2529523A1 (de) | Neue mittel und neue methoden zur behandlung klimakterischer ausfallserscheinungen | |
| DE4405591C1 (de) | Mittel zur postmenopausalen Hormonsubstitution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHN | Withdrawal |